Coffin Donna, Skinner Mark W, Thornburg Courtney D, Hayes Brendan K, Sannié Thomas, Kaeser Gwendolyn E, Chadwick Julia, Naccache Mayss, Pierce Glenn F
The World Federation of Hemophilia, Montreal, Quebec, Canada.
Institute for Policy Advancement Ltd, Washington, District of Columbia, USA.
Haemophilia. 2024 Nov;30(6):1298-1308. doi: 10.1111/hae.15100. Epub 2024 Oct 5.
The use of shared decision-making (SDM) in clinical settings is becoming more prevalent. The evolving and increasingly complex treatment landscape of haemophilia management has augmented the need and desire for SDM between patients and their healthcare team. SDM tools have been used in other chronic conditions and can be an effective form of education for patients and clinicians.
The World Federation of Hemophilia (WFH) partnered with people with haemophilia (PWH), patient advocacy groups, and healthcare practitioners to form an expert working group to develop an educational tool for PWH and their caregivers. The primary objectives included educating PWH on the available prophylactic treatments and facilitating discussion between PWH and their healthcare team.
The tool was proposed and developed by the expert working group, workshopped at conference round tables, and evaluated in two focus groups.
The interactive WFH SDM Tool guides users through the SDM treatment journey and provides an opportunity for reflection on current disease impact and treatment preferences, educational fact sheets and videos, and a comparison between treatment classes. Two forms of the SDM Tool are available: an online platform with a summary page that may be printed and shared and a printable workbook. All evidence in the tool is based on the prescribing information or phase III clinical trial publications. The Tool will be updated twice each year.
The WFH SDM Tool is the first available resource that translates published guidance on SDM in haemophilia into a practical, user-friendly tool aimed at facilitating patient-centred treatment decisions.
在临床环境中使用共同决策(SDM)正变得越来越普遍。血友病管理不断演变且日益复杂的治疗格局增加了患者与其医疗团队之间对共同决策的需求和渴望。共同决策工具已在其他慢性病中使用,并且可以成为对患者和临床医生有效的教育形式。
世界血友病联盟(WFH)与血友病患者(PWH)、患者倡导团体和医疗从业者合作,组建了一个专家工作组,为PWH及其护理人员开发一种教育工具。主要目标包括向PWH介绍可用的预防性治疗方法,并促进PWH与其医疗团队之间的讨论。
该工具由专家工作组提出并开发,在会议圆桌会议上进行研讨,并在两个焦点小组中进行评估。
交互式的WFH共同决策工具引导用户完成共同决策的治疗过程,并提供了一个机会,用于反思当前疾病的影响和治疗偏好、教育情况说明书和视频,以及不同治疗类别的比较。共同决策工具有两种形式:一个在线平台,其摘要页面可以打印和共享;还有一个可打印的工作手册。该工具中的所有证据均基于处方信息或III期临床试验出版物。该工具将每年更新两次。
WFH共同决策工具是首个可用资源,它将已发表的血友病共同决策指南转化为一个实用的、用户友好的工具,旨在促进以患者为中心的治疗决策。